Insider · CIK 0001055947
Bvf Partners L P/il
otherownerdirector
Files at XOMA (XOMA Royalty Corp), CBIO (GLYCOMIMETICS INC), IMUX (IMMUNIC, INC.), ELDN (Eledon Pharmaceuticals, Inc.), ALLK (Allakos Inc.), PVLA (PALVELLA THERAPEUTICS, INC.), FDMT (4D Molecular Therapeutics, Inc.), OLMA (Olema Pharmaceuticals, Inc.), MLTX (MoonLake Immunotherapeutics), THRD (Third Harmonic Bio, Inc.). First filing Oct 31, 2024, latest May 20, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $42M sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 55Moderate | XOMA Royalty Corp | $11M 392,723 shares | -27% | - | |
| 47Moderate | XOMAsell XOMA Royalty Corp | $17M 650,717 shares | -36% | - | |
| 61Notable | Third Harmonic Bio, Inc. | $14M 1,000,000 shares | -43% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | IMUX IMMUNIC, INC. | AGrant or award Stock Optionderivativeindirect: See footnote | +25,370 | $0.00 | $0 | 25,370 | 24 d ago |
| Jun 13, 2025 | CBIO GLYCOMIMETICS INC | JOther Common Stock | +657,308 | - | - | 707,116 | Jun 17, 2025 |
| Jun 13, 2025 | CBIO GLYCOMIMETICS INC | JOther Common Stock | +556,617 | - | - | 593,740 | Jun 17, 2025 |
| Jun 13, 2025 | CBIO GLYCOMIMETICS INC | JOther Common Stock | +56,079 | - | - | 62,383 | Jun 17, 2025 |
| Jun 13, 2025 | CBIO GLYCOMIMETICS INC | JOther Pre-Funded Warrants to Purchase Common Stockderivative | +304,098 | - | - | 304,098 | Jun 17, 2025 |
| Jun 13, 2025 | CBIO GLYCOMIMETICS INC | JOther Pre-Funded Warrants to Purchase Common Stockderivative | +257,515 | - | - | 257,515 | Jun 17, 2025 |
| Jun 13, 2025 | CBIO GLYCOMIMETICS INC | JOther Pre-Funded Warrants to Purchase Common Stockderivative | +25,944 | - | - | 25,944 | Jun 17, 2025 |
| Jun 11, 2025 | OLMA Olema Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to buy)derivativeindirect: See footnote | +24,150 | $0.00 | $0 | 24,150 | Jun 13, 2025 |
| Jun 5, 2025 | MLTX MoonLake Immunotherapeutics | AGrant or award Option to Buyderivativeindirect: See footnote | +6,682 | $0.00 | $0 | 6,682 | Jun 9, 2025 |
| May 16, 2025 | XOMA XOMA Royalty Corp | SOpen-market sale Common Stock, $0.0075 par value per share | -127,407 | $27.10 | $3.5M | 1,322,758 | May 20, 2025 |
| May 16, 2025 | XOMA XOMA Royalty Corp | SOpen-market sale Common Stock, $0.0075 par value per share | -265,316 | $27.10 | $7.2M | 1,267,545 | May 20, 2025 |
| May 15, 2025 | ALLK Allakos Inc. | DDisposition to issuer Common Stock, $0.001 par value | -8,679,726 | - | - | 0 | May 19, 2025 |
| May 15, 2025 | ALLK Allakos Inc. | DDisposition to issuer Common Stock, $0.001 par value | -6,777,935 | - | - | 0 | May 19, 2025 |
| May 15, 2025 | ALLK Allakos Inc. | DDisposition to issuer Common Stock, $0.001 par value | -855,211 | - | - | 0 | May 19, 2025 |
| Jan 24, 2025 | XOMA XOMA Royalty Corp | SOpen-market sale Common Stock, $0.0075 par value per share | -339,679 | $26.10 | $8.9M | 1,450,165 | Jan 28, 2025 |
| Jan 24, 2025 | XOMA XOMA Royalty Corp | SOpen-market sale Common Stock, $0.0075 par value per share | -85,776 | $26.10 | $2.2M | 1,532,861 | Jan 28, 2025 |
| Jan 24, 2025 | XOMA XOMA Royalty Corp | SOpen-market sale Common Stock, $0.0075 par value per share | -75,287 | $26.10 | $2.0M | 0 | Jan 28, 2025 |
| Jan 24, 2025 | XOMA XOMA Royalty Corp | SOpen-market sale Common Stock, $0.0075 par value per shareindirect: See footnote | -149,975 | $26.10 | $3.9M | 0 | Jan 28, 2025 |
| Jan 10, 2025 | OLMA Olema Pharmaceuticals, Inc. | DDisposition to issuer Common stock, $0.0001 par value | -235,450 | - | - | 2,655,977 | Jan 14, 2025 |
| Jan 10, 2025 | OLMA Olema Pharmaceuticals, Inc. | DDisposition to issuer Common stock, $0.0001 par value | -161,810 | - | - | 2,003,966 | Jan 14, 2025 |
| Jan 10, 2025 | OLMA Olema Pharmaceuticals, Inc. | DDisposition to issuer Common stock, $0.0001 par value | -22,740 | - | - | 347,970 | Jan 14, 2025 |
| Jan 10, 2025 | OLMA Olema Pharmaceuticals, Inc. | AGrant or award Pre-Funded Warrantderivative | +235,450 | - | - | 3,291,004 | Jan 14, 2025 |
| Jan 10, 2025 | OLMA Olema Pharmaceuticals, Inc. | AGrant or award Pre-Funded Warrantderivative | +161,810 | - | - | 2,627,590 | Jan 14, 2025 |
| Jan 10, 2025 | OLMA Olema Pharmaceuticals, Inc. | AGrant or award Pre-Funded Warrantderivative | +22,740 | - | - | 336,288 | Jan 14, 2025 |
| Dec 13, 2024 | PVLA PALVELLA THERAPEUTICS, INC. | JOther Common Stock, $0.001 par value | +234,323 | - | - | 371,916 | Dec 17, 2024 |
| Dec 13, 2024 | PVLA PALVELLA THERAPEUTICS, INC. | JOther Common Stock, $0.001 par value | +174,958 | - | - | 282,223 | Dec 17, 2024 |
| Dec 13, 2024 | PVLA PALVELLA THERAPEUTICS, INC. | JOther Common Stock, $0.001 par value | +29,648 | - | - | 38,961 | Dec 17, 2024 |
| Dec 4, 2024 | OLMA Olema Pharmaceuticals, Inc. | DDisposition to issuer Common stock, $0.0001 par value | -1,797,527 | - | - | 2,891,427 | Dec 4, 2024 |
| Dec 4, 2024 | OLMA Olema Pharmaceuticals, Inc. | DDisposition to issuer Common stock, $0.0001 par value | -1,418,736 | - | - | 2,165,776 | Dec 4, 2024 |
| Dec 4, 2024 | OLMA Olema Pharmaceuticals, Inc. | DDisposition to issuer Common stock, $0.0001 par value | -153,441 | - | - | 370,710 | Dec 4, 2024 |
| Dec 4, 2024 | OLMA Olema Pharmaceuticals, Inc. | AGrant or award Pre-Funded Warrantderivative | +1,797,527 | - | - | 1,797,527 | Dec 4, 2024 |
| Dec 4, 2024 | OLMA Olema Pharmaceuticals, Inc. | AGrant or award Pre-Funded Warrantderivative | +1,418,736 | - | - | 1,418,736 | Dec 4, 2024 |
| Dec 4, 2024 | OLMA Olema Pharmaceuticals, Inc. | AGrant or award Pre-Funded Warrantderivative | +153,441 | - | - | 153,441 | Dec 4, 2024 |
| Dec 4, 2024 | OLMA Olema Pharmaceuticals, Inc. | AGrant or award Pre-Funded Warrantderivative | +1,258,027 | $9.08 | $11M | 3,055,554 | Dec 4, 2024 |
| Dec 4, 2024 | OLMA Olema Pharmaceuticals, Inc. | AGrant or award Pre-Funded Warrantderivative | +1,047,044 | $9.08 | $9.5M | 2,465,780 | Dec 4, 2024 |
| Dec 4, 2024 | OLMA Olema Pharmaceuticals, Inc. | AGrant or award Pre-Funded Warrantderivative | +160,107 | $9.08 | $1.5M | 313,548 | Dec 4, 2024 |
| Nov 8, 2024 | FDMT 4D Molecular Therapeutics, Inc. | JOther Common Stock, $0.0001 par value | -3,062,000 | - | - | 830,237 | Nov 13, 2024 |
| Nov 8, 2024 | FDMT 4D Molecular Therapeutics, Inc. | JOther Common Stock, $0.0001 par value | -2,378,000 | - | - | 662,970 | Nov 13, 2024 |
| Nov 8, 2024 | FDMT 4D Molecular Therapeutics, Inc. | JOther Common Stock, $0.0001 par value | -240,000 | - | - | 87,911 | Nov 13, 2024 |
| Nov 8, 2024 | FDMT 4D Molecular Therapeutics, Inc. | JOther Pre-Funded Warrantderivative | +3,062,000 | - | - | 3,062,000 | Nov 13, 2024 |
| Nov 8, 2024 | FDMT 4D Molecular Therapeutics, Inc. | JOther Pre-Funded Warrantderivative | +2,378,000 | - | - | 2,378,000 | Nov 13, 2024 |
| Nov 8, 2024 | FDMT 4D Molecular Therapeutics, Inc. | JOther Pre-Funded Warrantderivative | +240,000 | - | - | 240,000 | Nov 13, 2024 |
| Oct 29, 2024 | THRD Third Harmonic Bio, Inc. | SOpen-market sale Common Stock | -538,420 | $14.30 | $7.7M | 1,794,218 | Oct 31, 2024 |
| Oct 29, 2024 | THRD Third Harmonic Bio, Inc. | SOpen-market sale Common Stock | -396,963 | $14.30 | $5.7M | 1,367,257 | Oct 31, 2024 |
| Oct 29, 2024 | THRD Third Harmonic Bio, Inc. | SOpen-market sale Common Stock | -64,617 | $14.30 | $924k | 176,692 | Oct 31, 2024 |
| Oct 29, 2024 | ELDN Eledon Pharmaceuticals, Inc. | POpen-market purchase Pre-funded Warrants to Purchase Common Stockderivative | +2,213,816 | $3.65 | $8.1M | 7,415,596 | Oct 31, 2024 |
| Oct 29, 2024 | ELDN Eledon Pharmaceuticals, Inc. | POpen-market purchase Pre-funded Warrants to Purchase Common Stockderivative | +2,100,244 | $3.65 | $7.7M | 6,235,545 | Oct 31, 2024 |
| Oct 29, 2024 | ELDN Eledon Pharmaceuticals, Inc. | POpen-market purchase Pre-funded Warrants to Purchase Common Stockderivative | +440,489 | $3.65 | $1.6M | 838,507 | Oct 31, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.